Related Experiment Video
Updated: Jul 13, 2026
12:09
Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4
Published on: December 31, 2013
10.1K
Identification of the TRPA1 cannabinoid-binding site
Tala Amawi1, Alaa Nmarneh1, Gilad Noy1
1The Institute for Drug Research (IDR), School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Israel.
Pharmacological Research
|October 5, 2024
Summary
Cannabinoids like THC and CBD activate the TRPA1 channel via a shared binding site, offering new targets for pain relief therapies. This research clarifies how cannabis compounds may reduce chronic pain.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Chronic pain is a leading reason for medical cannabis use, but its pain-relief mechanisms are unclear.
- Cannabis compounds, THC and CBD, effectively manage pain, though their molecular targets differ.
- TRPA1 channels are crucial pain pathway sensors and potential targets for cannabis-based pain therapies.
Purpose of the Study:
- To identify the specific binding site of THC and CBD on the TRPA1 channel.
- To understand the molecular mechanisms of cannabis-induced analgesia.
- To explore novel therapeutic targets for pain management.
Main Methods:
- Site-directed mutagenesis of the human TRPA1 channel.
- Functional assays to measure channel activity.
- Molecular modeling to visualize ligand-channel interactions.
Main Results:
- A shared cannabinoid-binding site (CBS) on TRPA1 was identified, involving residue Y840.
- Mutations at Y840 abolished THC and CBD activation, confirming the shared binding site.
- Molecular modeling showed distinct binding interactions for THC and CBD at Y840, with CBD also binding to an adjacent site at higher concentrations.
Conclusions:
- TRPA1 possesses an adaptable binding domain for non-electrophilic activators like THC and CBD.
- The identified TRPA1 binding site offers a novel target for developing cannabis-derived or synthetic analgesics.
- This research advances understanding of pain pathways and medical cannabis efficacy.
